Eisai Inc. announced today the presentation of four abstracts at the 2019 Gastrointestinal Cancers Symposium (#GI19), taking place in San Francisco from January 17-19, 2019. The presentations feature the latest data from post-hoc analyses of the pivotal phase 3...
CEO Tom Equels sat down with Proactive Investors at the 11th Annual Biotech Showcase in San Francisco. Equels says the company will begin clinical trials at the Roswell Park Comprehensive Cancer Center to start an oncology clinical study combining its dsRNA TLR3...
Translational Research In Oncology (TRIO), in collaboration with Novartis and under the direction of Dennis Slamon, MD, PhD, TRIO Chairman/Executive Director and Director of Clinical Translational Research at the University of California, Los Angeles Jonsson...
Strategikon Pharma, developer of the novel clinical trial planning, budgeting, outsourcing and vendor management tool Clinical Maestro™, announced the commercial release of its Pharma (Sponsor) Edition SOURCE™ module for automating key processes in clinical...
New study suggests loosening strict comorbidity criteria would open trials to thousands of previously exempt patients Jan. 10, 2019 By Diane Mapes / Fred Hutch News Service How do you make cancer clinical trials available to more patients? A new study published today...
Email
Text